{"title":"Eradication of Methicillin-Resistant <i>Staphylococcus aureus</i> in Cystic Fibrosis.","authors":"Aynur Guliyeva, Cansu Yilmaz Yegit, Muruvvet Yanaz, Mine Kalyoncu, Merve Selçuk Balci, Seyda Karabulut, Gamze Tastan, Burcu Uzunoglu, Hüseyin Arslan, Hakan Yazan, Gülay Bas Bilgin, Ayse Ayzıt Kılınc Sakallı, Almala Pinar Ergenekon, Saniye Girit, Erkan Cakır, Yasemin Gokdemir, Ela Erdem Eralp, Fazilet Karakoc, Bulent Karadag","doi":"10.1177/00099228251375413","DOIUrl":"https://doi.org/10.1177/00099228251375413","url":null,"abstract":"<p><strong>Introduction: </strong>Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) in cystic fibrosis (CF) impairs lung function and contributes to the progression of the disease. Optimal eradication regimens for new-onset MRSA infections in people with CF (pwCF) remain undefined.</p><p><strong>Materials and methods: </strong>This prospective, multicenter study evaluated a standardized, step-up MRSA eradication regimen in pwCF with new-onset MRSA infections between 2020 and 2022.</p><p><strong>Results: </strong>Ninety-one pwCF (52.7% male, median age: 9 years) were included. Our treatment regimen included oral rifampicin and co-trimoxazole or oral rifampicin and fusidic acid. Intravenous teicoplanin treatment was initiated in patients whose clinical condition was unstable. The eradication success rates after 1 year were 82.4%, 92.9%, and 55.6%, respectively. No significant changes in median FEV1% predicted or BMI <i>z</i>-scores were observed between MRSA-eradicated and non-eradicated groups at baseline or 12 months.</p><p><strong>Conclusion: </strong>A standardized step-up MRSA eradication protocol is effective for new-onset MRSA infections in pwCF. Randomized controlled trials are needed to confirm these findings.</p>","PeriodicalId":10363,"journal":{"name":"Clinical Pediatrics","volume":" ","pages":"99228251375413"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145205672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PediatricsPub Date : 2025-10-01Epub Date: 2025-03-25DOI: 10.1177/00099228251328142
Cody A Hostutler, Noelle Wolf, Katrice Stallworth, Rachel Herbst, Kathryn W Hoffses, Julie Pajek, David Curtis, Jennifer A Mautone, Andrew R Riley, Jeffrey D Shahidullah
{"title":"Primary Care Clinician Perspectives on Medication Prescribing for Child Mental Health Concerns.","authors":"Cody A Hostutler, Noelle Wolf, Katrice Stallworth, Rachel Herbst, Kathryn W Hoffses, Julie Pajek, David Curtis, Jennifer A Mautone, Andrew R Riley, Jeffrey D Shahidullah","doi":"10.1177/00099228251328142","DOIUrl":"10.1177/00099228251328142","url":null,"abstract":"<p><p>This study describes the frequency and comfort of pediatric primary care clinicians (PCCs) as it relates to initiating, continuing, and stopping medications for attention-deficit/hyperactivity disorder (ADHD), anxiety/depression, and sleep problems across age groups (≤5 years, 6-12, and 13+). Primary care clinicians (N = 148) within an integrated primary care national research consortium participated in an anonymous online survey including questions examining practice settings, provider characteristics, prescribing frequency, and prescribing comfort. Results indicate that comfort and prescribing practices vary by patient age, practice setting, provider experience, and presenting diagnoses. Primary care clinicians generally felt more comfortable prescribing for school-age children and older and prescribing for ADHD-related concerns. Primary care clinicians appeared similarly comfortable starting, maintaining, and stopping medications. Rural PCCs reported greater comfort initiating and managing medication. Results highlight the need for ongoing training and support for PCCs in managing common childhood mental health conditions. Implications for establishing collaborative infrastructure support and team-based care are discussed.</p>","PeriodicalId":10363,"journal":{"name":"Clinical Pediatrics","volume":" ","pages":"1264-1273"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143699876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PediatricsPub Date : 2025-10-01Epub Date: 2025-03-24DOI: 10.1177/00099228251328136
Muhittin Bodur, Rabia Tutuncu Toker
{"title":"Effectiveness and Safety of High-Dose Oral Phenobarbital in Children With Recurrent and Treatment-Refractory Seizures.","authors":"Muhittin Bodur, Rabia Tutuncu Toker","doi":"10.1177/00099228251328136","DOIUrl":"10.1177/00099228251328136","url":null,"abstract":"<p><p>In this study, we applied high-dose oral phenobarbital (PB) to children with recurrent and treatment-refractory seizures or recurrent status epilepticus and evaluated the effectiveness and safety of this treatment. We retrospectively reviewed patients' medical records who received oral high-dose PB treatment between January 2019 and July 2024. In this study, recurrent and treatment-refractory seizures was defined as the persistence of daily epileptic seizures or recurrent attacks of status epilepticus despite treatment with oral antiepileptic drugs or continuous intravenous midazolam therapy. High-dose oral PB therapy was performed on 11 patients (7 females and 4 males). The median age at the onset of epilepsy was 2 months (range: 0.06-132 months). The underlying disorders or comorbidity were genetic disorders (1q14 del, compound heterozygous for the <i>PNKP gene</i>, Wolf-Hirschhorn syndrome, ring chromosome 14 syndrome) in 4 patients, cerebral palsy in 2 patients, metabolic disorders (Zellweger syndrome, pyridoxine-dependent epilepsy) in 2 patients, traumatic brain injury and hypoxia, hemimegalencephaly, and ataxia and intellectual disability in 1 patient. The median age at initiation of high-dose PB therapy was 11 months (range: 2-203 months). The maximal dose of PB ranged from 6 to 14.7 mg/kg/d (median: 10 mg/kg/day). The maximal serum PB levels ranged from 33 to 56 µg/mL (median: 44 µg/mL). We evaluated the effectiveness of this treatment as follows: \"effective\" represented more than 50% seizure reduction, \"ineffective\" represented less than 50% seizure reduction, and \"exacerbation\" represented an increase in seizure frequency. In 7 of the 11 patients (63.6%), oral high-dose PB therapy was effective and was transiently effective in the other 4 patients. Adverse effects were noted in 6 patients (54.5%) during high-dose oral PB therapy: drowsiness in 5 patients and mild elevations in transaminases in 2 patients.</p>","PeriodicalId":10363,"journal":{"name":"Clinical Pediatrics","volume":" ","pages":"1259-1263"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143699870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PediatricsPub Date : 2025-10-01Epub Date: 2025-08-25DOI: 10.1177/00099228251326652
E Rodriguez Lien, E Zwemer, A Schwartz, P M Wilson, J C Babal, J R Serwint, K Sieplinga, K Donnelly, M Nichols, M Batra
{"title":"Relationship Between US Pediatric Resident Burnout and the Learning Environment.","authors":"E Rodriguez Lien, E Zwemer, A Schwartz, P M Wilson, J C Babal, J R Serwint, K Sieplinga, K Donnelly, M Nichols, M Batra","doi":"10.1177/00099228251326652","DOIUrl":"https://doi.org/10.1177/00099228251326652","url":null,"abstract":"<p><p>There is a paucity of literature evaluating the association between the pediatric residency learning environment (LE) and resident well-being. A cross-sectional study investigated the association between pediatric residents' LE satisfaction and their burnout, and whether LE subcomponents influenced LE satisfaction. A total of 2043 (69%) residents representing 46 pediatric programs responded, indicating that 40% of participants met the burnout classification. Residents not meeting burnout classification reported greater mean LE satisfaction (4.4 vs 3.6, <i>P</i> < .001), LE collaboration (4.4 vs 4.1, <i>P</i> < .001), resident mentorship (3.7 vs 3.1, <i>P</i> < .001), and resident education (4.1 vs 3.5, <i>P</i> < .001) than their colleagues with burnout. Residents reporting greater LE collaboration (<i>B</i> = 0.62, 95% confidence interval (CI) = 0.57-0.67, <i>P</i> < .001), greater resident mentorship (<i>B</i> = 0.51, 95% CI = 0.48-0.55, <i>P</i> < .001), and greater resident education (<i>B</i> = 0.72, 95% CI = 0.68-0.75, <i>P</i> < .001) had higher LE satisfaction, controlling for individual/program characteristics and clustering. This study demonstrates associations between LE satisfaction and burnout from a national group of pediatric residents.</p>","PeriodicalId":10363,"journal":{"name":"Clinical Pediatrics","volume":"64 9","pages":"1227-1233"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144945166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PediatricsPub Date : 2025-10-01Epub Date: 2025-04-12DOI: 10.1177/00099228251333302
Amine Aktar Karakaya, Edip Unal, Aslı Beştaş, Ozan Kapçay
{"title":"Is Insulin Resistance Present in Children With Subclinical Hypothyroidism?","authors":"Amine Aktar Karakaya, Edip Unal, Aslı Beştaş, Ozan Kapçay","doi":"10.1177/00099228251333302","DOIUrl":"10.1177/00099228251333302","url":null,"abstract":"<p><p>There are limited number of studies in the literature reporting the effect of subclinical hypothyroidism (SH) on insulin resistance and glucose metabolism in children. This study compared insulin, glucose and Homeostasis Model Assessment (HOMA-IR) values in 50 patients with SH and 50 healthy subjects. However, no significant difference was found between the groups. In addition, no significant correlation was observed between the TSH and fT4 levels and blood glucose, insulin and HOMA-IR values in patients with SH. Our study showed that SH does not lead to insulin resistance. Weight gain may be higher than normal in patients with SH. More comprehensive studies are needed for the long-term metabolic and cardiovascular effects of SH.</p>","PeriodicalId":10363,"journal":{"name":"Clinical Pediatrics","volume":" ","pages":"1365-1369"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143976875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PediatricsPub Date : 2025-10-01Epub Date: 2024-01-18DOI: 10.1177/00099228241229511
{"title":"Corrigendum to \"Virtual Schooling and Pediatric Mental Health During the COVID-19 Pandemic\".","authors":"","doi":"10.1177/00099228241229511","DOIUrl":"10.1177/00099228241229511","url":null,"abstract":"","PeriodicalId":10363,"journal":{"name":"Clinical Pediatrics","volume":" ","pages":"1346"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139485251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PediatricsPub Date : 2025-10-01Epub Date: 2025-05-09DOI: 10.1177/00099228251339047
Maria-Jesus Chasqueira, Pedro Paixão, Carla Barreiros, Madalena Tuna, Mónica Marçal, Paulo Paixão
{"title":"Prevalence of Torque Teno Virus in Portuguese Children Younger Than 3 Years Old: A Single-Center Study.","authors":"Maria-Jesus Chasqueira, Pedro Paixão, Carla Barreiros, Madalena Tuna, Mónica Marçal, Paulo Paixão","doi":"10.1177/00099228251339047","DOIUrl":"10.1177/00099228251339047","url":null,"abstract":"<p><p>The objective of this study was to determine the prevalence of Torque Teno virus (TTV) infection in Portuguese children younger than 3 years old and to compare its detection in blood <i>versus</i> saliva. Samples, 242 saliva and 20 plasma, were collected from neonates and children. A real-time polymerase chain reaction was applied to detect the TTV load. Eighteen paired samples of saliva and plasma were concordant for viral DNA, and a correlation between both was statistically significant. The prevalence of TTV was 75.5% in children and 3.6% in neonates, but it was not possible to determine the origin of positive cases in neonates, if they were true cases acquired before or after birth. Overall, the results suggest that TTV transmission occurs mainly in early childhood. Despite the small sample size, the good saliva/plasma correlation obtained is promising, but larger studies are needed to validate saliva samples for epidemiological studies for TV.</p>","PeriodicalId":10363,"journal":{"name":"Clinical Pediatrics","volume":" ","pages":"1419-1424"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}